Neogenomics (NEO) Revenue (2010 - 2025)
Neogenomics (NEO) revenue from Jun 30, 2010 to Dec 31, 2025. The TTM Neogenomics (NEO) revenue is $727M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Neogenomics (NEO) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +10.11% |
| 3 Years TTM | +12.58% |
| 5 Years TTM | +10.35% |
Annual Revenue change of Neogenomics (NEO)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $727M | +10.11% |
| 2024 | $661M | +11.65% |
| 2023 | $592M | +16.07% |
| 2022 | $510M | +5.24% |
| 2021 | $484M | +8.97% |
| 2020 | $444M | +8.71% |
| 2019 | $409M | +47.73% |
| 2018 | $277M | +15.19% |
| 2017 | $240M | +3.64% |
| 2016 | $232M | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | N/A |
| 2012 | $0 | N/A |
| 2011 | $0 | N/A |
| 2010 | $0 | N/A |
Comparison Neogenomics (NEO) five years revenue CAGR with competitors
Neogenomics (NEO) five years revenue CAGR is 10.35%.